Part Cells News Today

Researchers at Cold Spring Harbor Laboratory unveiled that T cells, a type of white blood cell, may hold the key to fighting aging and boosting the immune system.

Meet William Tse division director of hematology and oncology at MetroHealth in Cleveland. He has a passion for oncology and is focused on collaboration

Workflow for the generation of 3D tumor spheroids, co-cultured with T-cells as a proof-of-concept model for CAR T assays

Immunotherapies such as CAR T cells that have shown success in treating liquid tumors have had limited efficacy against solid tumors, including glioblastoma. Natural killer (NK) cells represent a promising approach for solid tumor treatment, and understanding mechanisms of NK-mediated cytotoxicity is important for cell therapy development. In this application note, Axion Biosystems quantifies the kinetics of both antibody-dependent cellular cytotoxicity (ADCC) and CAR NK-mediated cytolysis a

T cells engineered to express chimeric antigen receptors, commonly known as CAR T cells, have demonstrated the ability to help patients suffering from blood cancer.

A combination of oncolytic virotherapy acting in concert with immunotherapy shows promise for treatment-resistant cancers, according to new research.